Login

Traffic Data on SKY TG24 Business | Pasqualino Monti - CEO of ENAV 00:10:00

Share On Facebook Share On Twitter

Pasqualino Monti is Chief Executive Officer of ENAV since 28 April 2023.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Balancing Act: Navigating Market Neutrality Amid High Valuations | Sébastien Page, CIO , T. Rowe Price.
00:10:00
Warryn Robertson on Delivering Value in Global Listed Infrastructure | Warryn Robertson - Portfolio Manager and Analyst at Lazard Asset Management
00:10:00
M1's Long-Term Investing Approach vs. Robinhood's Trading Model Amidst Market Volatility
00:10:00
Goldman Sachs Asset Management's Alexa Gordon Discusses the Launch and Strategic Vision of the Goldman Sachs Community Municipal Bond ETF (NYSE Arca: GMUN) on The Exchange
00:10:00
Advancements in Sustainability Mandates: Insights from BBVA Asset Management
00:10:00
The Evolution of Habeas Corpus from Magna Carta to the English Habeas Corpus Act of 1679|Amanda Tyler
00:10:00
Financial Planning Through Divorce or Loss: A Compassionate Approach | Raquel Hinman - Founder & Principal of Hinman Financial Planning, Inc.
00:10:00
Thomas Peterffy, founder and chairman of Interactive Brokers, discusses his macroeconomic outlook and the return of retail investors with CNBC's Bob Pisani.
00:10:00
invests across the Americas|Miguel Armaza,Founding Partner,Gilgamesh Ventures
00:10:00
Navigating Family Business Transitions: Honesty and Decision-Making
00:10:00
Kristen on Recruiting at Jane Street: Culture, Collaboration, and Advice
00:10:00
Steadfast Leadership in Turbulent Times: Gerard O'Reilly's Strategies for Long-Term Client Focus at Dimensional Fund Advisors

© 2026 Nehu